Article Sidebar
Main Article Content
Abstract
Introduction: The risk of schizophrenia for suicide is 10%, of which 10% -15% of people with schizophrenia die of suicide at 20 years of follow-up. Aggressiveness is a factor to be watched out. Other factors are hallucinations, suicide, early-onset, history of schizophrenia, surveillance, age, gender, education, genetics, and the effect of depression. This study aimed to describe the sociodemographic profile, aggressiveness, and hallucinations of suicide in schizophrenic patients.
Methods: The design of this study is descriptive research. The number of samples in this study was 49 schizophrenic patients at risk of suicide. The risk of aggressiveness is measured by the Personality and Social Performance Score. Results. Of the 49 patients, it was found that the proportion of male patients was 31 people (63.3%) and 18 women (36.7%). Aggressive behavior based on PSP score was divided into modest aggressiveness of 22 people (44.9%), severe 20 people (40.8%), and very severe in two people (4.1%). Suicidal hallucinations were also found in 11 patients (22.4%).
Conclusion: There are markedly aggressive behavior and hallucinations of suicide in the majority of schizophrenic patients.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
